Page last updated: 2024-08-24

atorvastatin and Leukemia, Myeloid, Acute

atorvastatin has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Abuhantash, M; Arkill, KP; Ashworth, JC; Curd, J; Grundy, M; James, JR; Merry, CLR; Seedhouse, CH; Thompson, A; Wright, AJ1
Bae, HJ; Cho, EJ; Choi, JY; Han, KR; Hong, BK; Hong, SP; Hyon, MS; Jin, HY; Jung, HW; Kim, CY; Kim, KS; Kim, SY; Kim, U; Lee, JB; Lee, KH; Lee, KJ; Lee, SR; Lee, SY; Nam, CW; Park, CG; Park, SJ; Park, TH; Rhee, MY; Ryu, JK; Seol, SH; Shin, JH; Yang, DH; Yu, GW1

Trials

1 trial(s) available for atorvastatin and Leukemia, Myeloid, Acute

ArticleYear
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
    Journal of clinical hypertension (Greenwich, Conn.), 2023, Volume: 25, Issue:9

    Topics: Amlodipine; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Humans; Hypertension; Leukemia, Myeloid, Acute; Rosuvastatin Calcium; Treatment Outcome

2023

Other Studies

1 other study(ies) available for atorvastatin and Leukemia, Myeloid, Acute

ArticleYear
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML.
    International journal of molecular sciences, 2023, Feb-20, Volume: 24, Issue:4

    Topics: Atorvastatin; Bone Marrow; Humans; Hydrogels; Leukemia, Myeloid, Acute; Peptides

2023